Medical Industry Amount Leaders of Wednesday (BMY, ARNA, JNJ, HEB)

New York, NY -- (SBWIRE) -- 12/26/2012 -- Bristol-Myers Squibb (NYSE:BMY) yields 4.31% annually and has a market cap of $53.36 billion. Bristol-Myers Squibb, a biopharmaceutical company, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products that help patients prevail over serious diseases worldwide. It will pay a quarterly dividend of $0.35 on February 1, and its quarterly yield will be 1.08% based on Monday’s closing price of $32.46. The company has paid a quarterly dividend since 1970.

How Should Investors React To BMY Now? Find Out Here

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) percentage change jumped +1.04% to close at $8.72 with the total traded volume of 3.69 million shares more than average volume of 7.47 million shares.Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) clinical-staged biopharmaceutical company, which is devoted to develop and discover inventive therapies, the company offers latest and innovative medical advances for patients. Company’s lowest price during last trade was $8.64 while its highest price remained $8.97 for the day. ARNA’s total market capitalization is $1.89 billion along with 217.29 million shares outstanding. Its beta value stands at 0.25 points and its earning per shares remained $-0.53.

Will ARNA Continue To Move Higher? Find Out Here

Johnson & Johnson (NYSE:JNJ) are a holding company. The Company, along with its subsidiaries, is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Shares of Johnson & Johnson (NYSE: JNJ) are trading at $70.0364 and is +0.04% of its 50-day Moving Average price of $70.0066 and +1.91% from its 200-day Moving Average price of $68.7251. The average trading volume is 11462200 shares and its market capitalization is $194.1B.

Are these stocks a buy or sell? Let us help you decide, Check here

Hemispherx BioPharma, Inc (NYSE:HEB) reported a plunge of -2.86% after opening at the price of $0.30, its closing price for the day was $0.272. Hemispherx BioPharma Company’s earnings per share is $-0.11 while its beta value stands at 1.29 times. HEB’s total trading volume for the day was 3.04 million shares versus its average volume of 4.72 million shares. Company’s current market capitalization stands at $41.07 million along with 151.01 million shares.

Has HEB Found The Bottom and Ready To Move Up? Find Out Here

DISCLAIMER
Neither PennyStocksUpdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by PennyStocksUpdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.PennyStocksUpdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through PennyStocksUpdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..

Contact:
PennyStocksUpdate.biz
info@pennystocksupdate.biz